SVB Leerink Maintains Outperform on Applied Molecular, Lowers Price Target to $21
SVB Leerink analyst Joseph Schwartz maintains Applied Molecular (NASDAQ:AMTI) with a Outperform and lowers the price target from $60 to $21.
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's trading, 505 companies set new 52-week lows.
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 445 companies made new 52-week lows.
Applied Molecular Q3 EPS $(0.68) Down From $(0.48) YoY
Applied Molecular (NASDAQ:AMTI) reported quarterly losses of $(0.68) per share. This is a 41.67 percent decrease over losses of $(0.48) per share from the same period last year.